HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Multi-Media Imagery Program for Breast Cancer Patients (Phase II)

Signup
Browse Studies

City:   Seattle
State:   Washington
Zip Code:   98122
Conditions:   Breast Cancer
Purpose:   Global Objective: To improve quality of life and reduce stress for breast cancer survivors. To address the late-term and long-term effects of breast cancer treatment, as defined by the Institute of Medicine, including chemo brain, fatigue, sleep deprivation, stress, anxiety, depression, and PTSD. Phase II Aims: (1) To demonstrate the clinical efficacy (i.e., improved quality of life, stress reduction, participant satisfaction with product) of the "Envision the Rhythms of Life" program and (2) to establish the technical merits of the program's distance-delivery (videoconferencing hardware and software) and instructional technology (i.e., animations, graphically enhanced PowerPoint instructional materials, full-color program manuals, art-as-imagery, and audio-imagery). "Envision the Rhythms of Life" instructs breast cancer survivors in the practice of individualized, emotionally supportive, and biologically accurate imagery and consists of 5, 4-hour long, interactive classes and between-class instructor support. Instructional Options: Option 1 delivers the program technology (animations, PowerPoint, manuals, art, audio-art) with instructor and participants in the same room. Option 2 delivers the program at-a-distance, to a small group of, via videoconferencing software and camera systems (Alaska and Seattle) to low, moderate or high bandwidth areas. Each option delivers program three times (total of 45 participants for each option). A website portal provides all program information and materials. Design and Method: Program will be delivered to 135 breast cancer survivors who have completed conventional care (surgery, radiation, IV chemotherapy) for at least six weeks. Differences in option 1 and 2 outcomes will be compared to each other and to controls; combined outcomes of option 1 and 2 will be compared to controls; and waitlist control outcomes will be compared to their extended baseline. Hypothesis: Options 1 and 2 will both produce significantly better outcomes than waitlist control group.
Study Summary:   DESCRIPTION: To improve quality of life and reduce stress for breast cancer survivors. Phase II Aims: (1) To demonstrate the clinical efficacy (i.e., improved quality of life, stress reduction, participant satisfaction with product) of the "Envision the Rhythms of Life" program and (2) to establish the technical merits of the program's distance-delivery (videoconferencing hardware and software) and instructional technology (i.e., animations, graphically enhanced PowerPoint instructional materials, full-color program manuals, art-as-imagery, and audio-imagery). "Envision the Rhythms of Life" instructs breast cancer survivors in the practice of individualized, emotionally supportive, and biologically accurate imagery and consists of 5, 3-hour long, interactive classes and between-class instructor support. Instructional Options: Option 1 delivers the program technology (animations, PowerPoint, manuals, art, audio-art) with instructor and 15 participants in the same room. Option 2 delivers the program at-a-distance, to a small group of 15, via videoconferencing software and camera systems (Alaska and Seattle) to low, moderate or high bandwidth areas. Each option delivers program three times (total of 45 participants for each option). A website portal provides all program information and materials. Design and Method: Program will be delivered to 135 breast cancer survivors who have completed conventional care (surgery, radiation, IV chemotherapy) for at least six weeks. Differences in option 1 and 2 outcomes will be compared to each other and to controls; combined outcomes of option 1 and 2 will be compared to controls; and waitlist control outcomes will be compared to their extended baseline. Long-Term Objectives: This innovative project integrates technology with bandwidth-sensitive multi-media conferencing strategies to deliver a virtual mind-body, imagery intervention. The technology will allow seamless program delivery to interested survivors across the country during Phase III. Instructional technology, designed per Phase I participant feedback, will serve to `jump-start' potent imagery practice and will optimize clinical efficacy. Commercial application and survivor participation is not limited by location, work schedule, or health status, addressing issues of barriers to access of care. Although desirable, instructional options 1 and 2 do not require survivors to have computer skills or internet access. The program is designed to be culturally sensitive and supports individual spiritual practices. PUBLIC HEALTH RELEVANCE: This program addresses NCI and IOM summary reports that call for individualized supportive care for cancer survivors suffering disease-related distress. Changes in two disease-education program modules would allow the program to be used as supportive therapy for other forms of cancer across the country.
Criteria:   Inclusion Criteria: - Participants must be a community-dwelling member 18 years of age or older. - The participant must be at least 18 because the assessment tools are not validated for use in minors. - Participants should be able to read, write, and speak English. - Participants must have been diagnosed with breast cancer and have completed surgery, which did not include Level III dissection of the axilla. - Participants must obtain verification of diagnosis and treatment from their physician. - Participants must agree to complete assessment instruments and take part in psychophysiological data gathering at baseline, 8 and 17 weeks and to provide required demographic information. - Participants must sign informed consent, stating he/she understands the nature of the research and that he/she wishes to participate in the study. - - Participants must agree to complete the required diaries, graphs and notebooks related to behavior assessment. - Participants must display the ability to understand and respond to the assessment process and must demonstrate they are oriented to person, place, and time. - Participants must agree to fully participate in all five imagery classes and to practice imagery skills for 20 minutes a day for 17 weeks. - Participants must have completed major cancer treatment (i.e., surgery, and/or radiation and/or IV chemotherapy) for six weeks; participant must be visual and hearing capable. - Oral chemotherapy does not preclude participation. Exclusion Criteria: - Participant will be excluded if he/she has a history of uncontrolled epileptic seizures. - The investigators will exclude patients who cannot speak, read and write English. - Patients will be excluded if they are not oriented to place, person, and time. - Participants will be excluded if they have a major psychiatric diagnosis (schizophrenia, bi-polar disorder). - The investigators will exclude patients who received a Level III dissection of the axilla. - Participants will be excluded if they are visually or hearing impaired. - Although imagery can be modified for the visually or hearing impaired, that model is significantly different from an imagery program for the visual and hearing capable.
NCT ID:   NCT01034215
Primary Contact:   Principal Investigator
Lynda W Freeman, Ph.D.
Mind Matters Research LLC

Lynda W Freeman, Ph.D.
Phone: 907-868-7737
Email: lfreeman@gci.net
Backup Contact:   Email: ssutton@mindmattersresearch.com
Sue Sutton
Phone: 907-868-7737
Location Contact:   Seattle, Washington 98122
United States

Lynda W Freeman, Ph.D.
Phone: 907-868-7737
Email: lfreeman@gci.net

Site Status: Recruiting

Click here to see:
  • Clinical trials for Breast Cancer in Seattle, Washington

Data Source:   ClinicalTrials.gov
Date Processed:   May 17, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"
First Name:  
Last Name:  
Email Address:  
Confirm Email:    
Daytime Phone (eg. 555-555-5555):  
City:  
State:
Zip Code:    
Best Time to Call:  
Questions/Comments:  
  • NEARBY STUDIES

Within 25 Miles

Antidepressant Induced Sexual Dysfunction - Seattle WA

Bipolar Disorder - Seattle WA

Pediatric Depression - Kirkland WA

Pediatric Depression - Seattle WA

Generalized Anxiety Disorder - Seattle WA

Crohn's Disease - Seattle WA

Depression - Seattle WA

Treatment Resistant Depression - Seattle WA

Gout - Port Orchard WA

Binge Eating Disorder - Seattle WA

Multiple Sclerosis - Seattle WA

Low Back Pain and Constipation - Bothell WA

Anti-Depressant Induced Sexual Dysfunction - Seattle WA

Uncontrolled Angina (Adult Stem Cell Research) - Seattle WA

Uncontrolled Angina (Adult Stem Cell Research) - Seattle WA

Irritable Bowel Syndrome (with diarrhea) - Seattle WA

Brain Tumor (Glioblastoma) - Seattle WA

Chronic Sciatic Pain - Bellevue WA

Adult ADHD - Seattle WA

Within 50 Miles

Postherpetic Neuralgia (Post-shingles pain) - Tacoma WA

Within 100 Miles

Irritable Bowel Syndrome (with diarrhea) - Wenatchee WA

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.